June 14, 2023, Edison, NJ – Hackensack Meridian Health and its Bear’s Den innovation accelerator program are making a strategic investment in Canary Speech, a company that uncovers valuable insights to disease and well-being encoded in human speech.
Canary’s patented technology monitors a variety of health factors in a fast, non-invasive, and accurate way: by assessing “digital biomarkers” in the human voice to explain or predict energy levels, and health-related outcomes. The technology tracks the presence and severity of a variety of targeted diseases, such as anxiety, depression, and cognitive decline. The resulting Vocal Scores can replace subjective measurements with objective, actionable care solutions.
“This is a fascinating innovation, and we’re eager to support a promising way to leverage technology for wellness,’’ said Robert C. Garrett, FACHE, chief executive officer of Hackensack Meridian Health. “Artificial intelligence is impacting every aspect of modern life, and our health network wants to help accelerate the efforts of companies like Canary Speech.”
“We are thrilled to partner with Hackensack Meridian Health, and welcome their support,” said Henry O’Connell, Canary Speech chief executive officer and co-founder.
Canary Speech’s patented speech analysis technology provides clinical-grade screening for mood states and disease using proprietary machine-learning modeling.
The human voice inherently reveals both emotional and physiological states. Canary’s technology unlocks voice as a vital sign unto itself, modeling both acoustic and linguistic features to measure stress, mood, and energy within the patterns, inflections, and timing of those words.
Developed by the neurology and speech AI team behind Amazon Alexa, Canary Speech powers first-of-its-kind insight into the full applications of vocal biomarkers in healthcare.
Aimed at providing proactive screening in real-time, Canary’s algorithms are built to augment standardized clinical assessments like GAD7 (for anxiety) and PHQ8 (for depression). The company provides clinical-grade screening to detect changing emotional wellness states and mental-health deterioration in real-time.
Beyond anxiety, stress, energy, and mental health status, Canary Speech is also researching the assessment of a series of other afflictions through the voice, including: Huntington’s disease, Alzheimer’s disease, Parkinson’s disease, PTSD, and others.
“Investment of this kind is a smart strategic move, with an eye toward the future,” said Ihor Sawczuk, M.D., FACS, Hackensack Meridian Health’s president of Academics, Research and Innovation, founding chair of the Hackensack Meridian Health Research Institute.
Launched in 2017, the Bear’s Den features a panel of experts, including Hackensack Meridian Health CEO Garrett, leading physicians, key network executives, venture capitalists, patent attorneys, who gather regularly to vet proposals from entrepreneurs. The health network’s novel incubator has vetted many products and strategies to streamline care delivery, reduce infections, lower hospital readmissions and help patients partner in their care with physicians. The program has also invested in promising innovative companies, like Canary Speech.
ABOUT HACKENSACK MERIDIAN HEALTH
Hackensack Meridian Health is a leading not-for-profit health care organization that is the largest, most comprehensive and truly integrated health care network in New Jersey, offering a complete range of medical services, innovative research and life-enhancing care. The network has 18 hospitals and more than 500 patient care locations, which include ambulatory care centers, surgery centers, home health services, long-term care and assisted living communities, ambulance services, lifesaving air medical transportation, rehabilitation centers, urgent care centers, physician practice locations, and a fitness and wellness center. With more than 35,000 team members and 7,000 physicians, Hackensack Meridian Health is a distinguished leader in health care philanthropy and committed to the health and well-being of communities throughout New Jersey.
The network’s notable distinctions include having more U.S. News-ranked hospitals than any other health system in New Jersey, as ranked by U.S. News & World Report, 2022-23. Hackensack University Medical Center is nationally-ranked by U.S. News & World Report in four specialties, more than any other hospital in New Jersey. Joseph M. Sanzari Children’s Hospital at Hackensack University Medical Center, and K. Hovnanian Children’s Hospital at Jersey Shore University Medical Center, are ranked #1 in the state and top 20 in the Mid-Atlantic Region by U.S. News & World Report’s 2022-23 Best Children’s Hospital Report. Additionally, their combined nephrology program ranks in the top 50 in the United States. To learn more, visit www.hackensackmeridianhealth.org.
ABOUT CANARY SPEECH
Canary Speech is the global leader in the speech digital biomarker industry by achieving real time vocal analysis on as little as 40 seconds of speech using smart devices. Canary Speech is seeking to advance speech and language applications for the hospital, health and wellness, and pharmaceutical markets, the Utah-based company enhances patient care and outcomes by improving quality of care and quality of life with its patented AI speech technology. Canary Speech technology also provides the opportunity to enhance telemedicine and remote medical services. For more information, visit www.canaryspeech.com.
ABOUT HACKENSACK MERIDIAN HEALTH RESEARCH INSTITUTE (HMHRI):
HMHRI leads and organizes a connected ecosystem bringing together clinicians, scientists, and educators to respond to the health problems of our time, in real-time. HMHRI is dedicated to accelerating discovery, innovation, and translation of scientific breakthroughs that address unmet clinical needs.
